Canntab Therapeutics; two MMJ DEVELOPMENTS and updated news.
Canntab Therapeutics Limited (CSE: PILL) (“Canntab” or the “Company”) is pleased to announce two recent developments: (i) an update on its application for a Dealer’s License with Health Canada; and (ii) its Australian joint venture partner has obtained a license to import medical cannabis products.
Application for a Dealer’s License with Health Canada.
The Company has engaged an experienced consultant for the purposes of finalizing and submitting an application to obtain a Health Canada Dealer’s License (“Dealer’s License”) under the Controlled Drugs and Substances Act (“CDSA”) and its associated regulations. The Dealer’s License will allow Canntab to continue with the development of its proprietary products including the XR Tablet and will allow Canntab to manufacture and sell the products in Canada and elsewhere.
Further, the Dealer’s License, when combined with an export permit that the Company intends to apply for after receiving its Dealer’s License, will allow the Company to export its proprietary Extended Release Tablet (“XR Tablet”) to certain international markets. Trevor Moore, a veteran of the Canadian medical cannabis industry, has been retained by the Company to assist in preparing its application for a Dealer’s License. Mr. Moore has previously helped two Licensed Producers obtain their licenses, and is an expert in the areas of quality assurance, regulatory compliance and government relations.
Australian Joint Venture
Canntab entered into a joint venture agreement with Queensland Bauxite Ltd. (“QBL”) and its wholly owned subsidiary Vitacan Pty Ltd. (“Vitacan”) (the “Joint Venture Agreement”) pursuant to the Joint Venture Agreement the parties shall manufacture, distribute and sell Canntab’s proprietary products including its XR cannabis tablets in Australia. The Joint Venture may extend to other territories in Asia. Pursuant to the Joint Venture Vitacan has agreed to contribute the
first $1,000,000 US of capital required by the Joint Venture.
“We are very excited to expand Canntab’s business to the Australian market which is a very progressive market for the development and sale of marijuana and marijuana products,” said Jeffrey Renwick, the CEO of Canntab.
Australian JV Partner Obtains Import License
The Company’s Australian joint venture partner, Queensland Bauxite Ltd. (“Queensland Bauxite”) and its subsidiary, Medical Cannabis Limited (“MCL”), recently announced that MCL entered into a binding memorandum of understanding (“MOU”) with Burleigh Heads Cannabis (“BHC”), which holds an import license issued by the Australian Office of Drug Control. Under the terms of the MOU, BHC will provide the import and storage services for MCL’s international medical cannabis products.
About Queensland Bauxite
Queensland Bauxite Ltd is an Australian listed company focused on the exploration and development of its bauxite tenements in Queensland and New South Wales. The Company’s lead project is the South Johnstone Bauxite Deposit in northern Queensland which has rail running through the project area and is approximately 15-24 kilometres from the nearest deep water port. The Company intends to become a bauxite producer with a focus on commencing production at South Johnstone as early as possible. The Company also pursues additional investment opportunities, and has acquired a 55% shareholding in Medical Cannabis Limited, an Australian leader in the hemp and Cannabis industries.
The subsidiary of QBL is going from one milestone to another - ones we see the revenue start coming, this will gain the value of QBL.
Considering the relative low valuation today, the leverage will be very strong one`s revenues are increasing. I reckon the first quarterly report, will not be so strong revenue; it will take some months to get the hemp wellknown within the mainstream media and awareness.
Within the second quaerterly report, the hemp revenue will be larger. It will also show the first revenues from the first sales of MMJ medics.
We have exciting times ahead of us - to be taking part of this historic event is a blessing. Hemp and MMJ will change many peoples lifes.
See QBL-board and website. https://www.queenslandbauxite.com/
Read More: https://investorshangout.com/post/view?id=502...z5EG3Fzrvj
Canntab Therapeutics Limited (CSE: PILL) (“Canntab” or the “Company”) is pleased to announce two recent developments: (i) an update on its application for a Dealer’s License with Health Canada; and (ii) its Australian joint venture partner has obtained a license to import medical cannabis products.
Application for a Dealer’s License with Health Canada.
The Company has engaged an experienced consultant for the purposes of finalizing and submitting an application to obtain a Health Canada Dealer’s License (“Dealer’s License”) under the Controlled Drugs and Substances Act (“CDSA”) and its associated regulations. The Dealer’s License will allow Canntab to continue with the development of its proprietary products including the XR Tablet and will allow Canntab to manufacture and sell the products in Canada and elsewhere.
Further, the Dealer’s License, when combined with an export permit that the Company intends to apply for after receiving its Dealer’s License, will allow the Company to export its proprietary Extended Release Tablet (“XR Tablet”) to certain international markets. Trevor Moore, a veteran of the Canadian medical cannabis industry, has been retained by the Company to assist in preparing its application for a Dealer’s License. Mr. Moore has previously helped two Licensed Producers obtain their licenses, and is an expert in the areas of quality assurance, regulatory compliance and government relations.
Australian Joint Venture
Canntab entered into a joint venture agreement with Queensland Bauxite Ltd. (“QBL”) and its wholly owned subsidiary Vitacan Pty Ltd. (“Vitacan”) (the “Joint Venture Agreement”) pursuant to the Joint Venture Agreement the parties shall manufacture, distribute and sell Canntab’s proprietary products including its XR cannabis tablets in Australia. The Joint Venture may extend to other territories in Asia. Pursuant to the Joint Venture Vitacan has agreed to contribute the
first $1,000,000 US of capital required by the Joint Venture.
“We are very excited to expand Canntab’s business to the Australian market which is a very progressive market for the development and sale of marijuana and marijuana products,” said Jeffrey Renwick, the CEO of Canntab.
Australian JV Partner Obtains Import License
The Company’s Australian joint venture partner, Queensland Bauxite Ltd. (“Queensland Bauxite”) and its subsidiary, Medical Cannabis Limited (“MCL”), recently announced that MCL entered into a binding memorandum of understanding (“MOU”) with Burleigh Heads Cannabis (“BHC”), which holds an import license issued by the Australian Office of Drug Control. Under the terms of the MOU, BHC will provide the import and storage services for MCL’s international medical cannabis products.
About Queensland Bauxite
Queensland Bauxite Ltd is an Australian listed company focused on the exploration and development of its bauxite tenements in Queensland and New South Wales. The Company’s lead project is the South Johnstone Bauxite Deposit in northern Queensland which has rail running through the project area and is approximately 15-24 kilometres from the nearest deep water port. The Company intends to become a bauxite producer with a focus on commencing production at South Johnstone as early as possible. The Company also pursues additional investment opportunities, and has acquired a 55% shareholding in Medical Cannabis Limited, an Australian leader in the hemp and Cannabis industries.
The subsidiary of QBL is going from one milestone to another - ones we see the revenue start coming, this will gain the value of QBL.
Considering the relative low valuation today, the leverage will be very strong one`s revenues are increasing. I reckon the first quarterly report, will not be so strong revenue; it will take some months to get the hemp wellknown within the mainstream media and awareness.
Within the second quaerterly report, the hemp revenue will be larger. It will also show the first revenues from the first sales of MMJ medics.
We have exciting times ahead of us - to be taking part of this historic event is a blessing. Hemp and MMJ will change many peoples lifes.
See QBL-board and website. https://www.queenslandbauxite.com/
Read More: https://investorshangout.com/post/view?id=502...z5EG3Fzrvj
Robert
